VA IM: Open Payments
NPI 1396010229 · SAINT PETERSBURG,, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 11 payments from 6 companies in 2025. Trend: 2023 $45 · 2024 $306 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $84 |
| Lilly USA, LLC | 2 | $46 |
| ABBVIE INC. | 2 | $41 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
| Amgen Inc. | 1 | $16 |
Products named: Ozempic, MOUNJARO, Wegovy, TRELEGY ELLIPTA, UBRELVY, Cologuard Collection Kit, Rybelsus, QULIPTA.
Industry payments across FL — which companies pay providers there.
